NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Osmo

Osmo

Private
Elizabeth, New JerseyHealthcare & Life Scienceshttps://www.osmo.ai/

Last Round

Series B

Feb 4, 2026

Total Funding Raised

$133.5M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Osmo is a technology company that develops an artificial intelligence platform designed to digitize the sense of smell for fragrance creation and disease detection.

Sector

Healthcare & Life Sciences

Verticals

Fashion & Beauty, Biotechnology, Compliance & Risk, NLP & Conversational AI

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

olfactory sciencedigital scentAI fragrancescent digitizationfragrance housemolecular informaticsnon-animal testingsafety assessmentodor perceptionAI-powered olfactionpredictive toxicologyingredient discoverygraph neural networksdigital olfactionfragrance tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Osmo Comparables

Compare Osmo with similar companies based on industry and business-model similarity.

Osmo comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Patina Corp
79%
Moodify
78%
Sensorygen
71%

Osmo Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BFeb 4, 2026
GrantNov 8, 2023
Series AJan 26, 2023

Key People

Founding team and executive leadership

Alex Wiltschko

Founder and CEO

Founding Team

Nate Pearson

CFO

Executive Team

Mateusz Brzuchacz

Chief Operating Officer

Executive Team

Osmo Investors

Notable investors and investment history

Osmo investors
InvestorRounds
AmploSeries B
GVSeries A
Atreides ManagementSeries B
Arena HoldingsSeries A
Lux CapitalSeries A
Moore Strategic VenturesSeries A
Two Sigma VenturesSeries B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 4, 2026

    $70M round completed.

  • Jan 30, 2026

    AI model launched to replace animal testing for skin irritation.

Osmo Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Osmo Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Osmo's valuation, stock price, and market status.

Firmographic Details

HeadquartersElizabeth, New Jersey
Employee Range123
Year Founded2022
Last FundingFeb 4, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.